InCrowd Debuts InCrowd Essentials, A Streamlined Approach To Traditional Life Science Market Tracking  

by draivika_incrowd | Sep 19, 2022

Syndicated research that delivers strategic insights weeks sooner than traditional market tracking,Essentials helps brand managers identify opportunities, stay ahead of the competition WATERTOWN MA September 19, 2022—InCrowd, a pioneer of real-time, automated insights...

InCrowd Wins Silver Stevie® Award in 2022 International Business Awards® Program  

by draivika_incrowd | Aug 18, 2022

Judges commend InCrowd global instant market insights offering for life science as “a very elegant solution to the problem of getting quick insights from health care providers”   WATERTOWN MA August 17, 2022—InCrowd, the pioneer of real-time, automated insights for...

Two-Thirds of US Doctors Say Mobile Diabetes Apps Help Patients Stay In Touch with Disease Management, In New InCrowd Instant Insights Data

by draivika_incrowd | Dec 1, 2021

However, doctors show less agreement on impact on outcomes, with 53% saying apps provide better health outcomes, 47% that apps are highly effective in managing T2D  WATERTOWN, MA, December 1, 2021—As the...

88% of US Pediatricians Highly Recommend COVID-19 Vaccines to All Patients Ages 5-11 When Available, Say New InCrowd Instant Insights Data

by draivika_incrowd | Nov 3, 2021

Only 5% are concerned about potential risks of severe conditions such as myocarditis and/or pericarditis; 30% say their practices are performing extra outreach to families of color with eligible patient WATERTOWN, MA, November 3, 2021—New...

Despite Recent FDA Hold, US Cancer Specialists Are Enthusiastic About CAR T-Cell Therapies, Says InCrowd Instant Insights Data

by draivika_incrowd | Oct 29, 2021

42% expect clinical trials will reconvene as soon as more data are released  WATERTOWN, MA October 29, 2021—Despite the FDA’s recent hold on select chimeric antigen receptor (CAR) T-cell clinical trials for cancer treatments using allogeneic...